Hidenori Karasaki
Hidenori Karasaki publishes mostly in Surgery, Oncology and Cancer Research, on topics such as Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #5,720,372 of 7,710,434 ranked researchers
- Rank in Japan
- #202,509 of 383,136
- Works
- 90
- Citations
- 807
- Citations per work
- 9.0
What does Hidenori Karasaki research?
Hidenori Karasaki's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5561.0%
- Medicine5561.0%
- Everything else1921.0%
- Life Sciences1618.0%
- 1Surgery26% of their works
- 2Oncology24% of their works
- 3Cancer Research12% of their works
- 4Molecular Biology6% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Epidemiology4% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Cancer Genomics and Diagnostics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatitis Pathology and Treatment
- Gastrointestinal Tumor Research and Treatment
- Renal cell carcinoma treatment
- Single-cell and spatial transcriptomics
- Gastrointestinal disorders and treatments
Which keywords describe Hidenori Karasaki's research?
The keywords of their largest research topics: Immunotherapy, Pancreatic Cancer, Surgical Complications, Epidemiology, Prognostic Factors, Cancer Genomics, Mutational Signatures and Surgical Management.
- Single-Cell
- Intussusception
- Metastatic
- Imatinib Mesylate
- Acute Pancreatitis
- Cholangiocarcinoma
- Surgical Management
- Cancer Genomics
- Epidemiology
- Pancreatic Cancer
- Immunotherapy
- Surgical Complications
- Prognostic Factors
- Mutational Signatures
- Biliary Tract Cancer
- Treatment
- Chronic Pancreatitis
- Sunitinib
- Renal Cell Carcinoma
- Meckel's Diverticulum
- Transcriptomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Immunotherapy422 topics
- Pancreatic Cancer371 topic
- Surgical Complications371 topic
- Epidemiology273 topics
- Prognostic Factors263 topics
- Cancer Genomics221 topic
- Mutational Signatures221 topic
- Surgical Management212 topics
- Biliary Tract Cancer151 topic
- Cholangiocarcinoma151 topic
- Treatment92 topics
- Acute Pancreatitis81 topic
- Chronic Pancreatitis81 topic
- Imatinib Mesylate61 topic
- Sunitinib61 topic
- Metastatic51 topic
- Renal Cell Carcinoma51 topic
- Intussusception41 topic
- Meckel's Diverticulum41 topic
- Single-Cell41 topic
- Transcriptomics41 topic
Where does Hidenori Karasaki work?
Hidenori Karasaki's main affiliation in the publication record is Sapporo Higashi Tokushukai Hospital, Japan.
How many publications and citations does Hidenori Karasaki have?
OpenAlex counts 90 works and 807 citations for Hidenori Karasaki, an h-index of 15, ranking #5,720,372 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hidenori Karasaki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.